MARY STAMPLE: Open Payments
NPI 1750096145 · APPLETON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 22 payments from 9 companies in 2025. Trend: 2023 $648 · 2024 $517 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $71 |
| Neurocrine BioSciences, Inc. | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Collegium Pharmaceutical, Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Lundbeck LLC | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Sage Therapeutics, LLC | 1 | $16 |
Products named: COBENFY, INGREZZA, REXULTI, Jornay PM, CAPLYTA, ABILIFY MAINTENA, FANAPT, TRINTELLIX.
Industry payments across WI — which companies pay providers there.
